These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15670053)

  • 1. No influence of a butterfly device on routine coagulation assays and D-dimer measurement.
    Lippi G; Salvagno GL; Guidi GC
    J Thromb Haemost; 2005 Feb; 3(2):389-91. PubMed ID: 15670053
    [No Abstract]   [Full Text] [Related]  

  • 2. D-Dimer Testing: Laboratory Aspects and Current Issues.
    Thachil J; Lippi G; Favaloro EJ
    Methods Mol Biol; 2017; 1646():91-104. PubMed ID: 28804821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of specimen collection on routine coagulation assays and D-dimer measurement.
    Lippi G; Guidi GC
    Clin Chem; 2004 Nov; 50(11):2150-2. PubMed ID: 15502084
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of two rapid D-dimer assays for the exclusion of venous thromboembolism.
    Reber G; de Moerloose P; Coquoz C; Bounameaux H
    Blood Coagul Fibrinolysis; 1998 Jun; 9(4):387-8. PubMed ID: 9690811
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited interobserver agreement in the SimpliRED D-dimer assay.
    Perzanowski C; Eiger G
    J Thromb Haemost; 2003 Apr; 1(4):849-50. PubMed ID: 12871425
    [No Abstract]   [Full Text] [Related]  

  • 8. D-dimer assays: the current status and new assay technologies.
    Dempfle CE
    Thromb Res; 2006; 118(5):569-71. PubMed ID: 16139335
    [No Abstract]   [Full Text] [Related]  

  • 9. [FDP-D dimer and FDP-E fraction (FDP-E)].
    Amemiya N
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():608-10. PubMed ID: 15658402
    [No Abstract]   [Full Text] [Related]  

  • 10. D-dimer and fibrinogen/fibrin degradation products.
    Stang LJ
    Methods Mol Biol; 2013; 992():415-27. PubMed ID: 23546734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer.
    Bronić A; Coen Herak D; Margetić S; Milić M
    Biochem Med (Zagreb); 2019 Jun; 29(2):020503. PubMed ID: 31223257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Soluble fibrin monomer complex (SFMC), soluble fibrin monomer (SFM)].
    Kawai Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():600-3. PubMed ID: 15658400
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemostasis test compatibility with capped and uncapped tubes.
    Finnegan K; Cutsforth G
    Clin Lab Sci; 2011; 24(4):215-20. PubMed ID: 22288219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrinogen and fibrin degradation products by leukocyte elastase].
    Madoiwa S; Sakata Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():611-4. PubMed ID: 15658403
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence that fibrin(ogen) degradation products (FDP) are adequately quantified in citrated plasma defibrinated at low pH.
    Godal HC; Hamborg T
    Scand J Haematol; 1984 Jan; 32(1):46-8. PubMed ID: 6695150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor performance of D-dimer in excluding venous thromboembolism among patients with lymphoma and leukemia.
    Qdaisat A; Soud RA; Wu CC; Rojas Hernandez CM; Li J; Meng QH; Abdel-Razeq H; Yeung SJ
    Haematologica; 2019 Jun; 104(6):e265-e268. PubMed ID: 30630988
    [No Abstract]   [Full Text] [Related]  

  • 17. Performance of the automated and rapid STA Liatest D-dimer on the STA-R analyzer.
    Waser G; Kathriner S; Wuillemin WA
    Thromb Res; 2005; 116(2):165-70. PubMed ID: 15907532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factors in renal adenocarcinoma.
    Sufrin G; Mink I; Fitzpatrick J; Moore R; Murphy GP
    J Urol; 1978 Jun; 119(6):727-30. PubMed ID: 660756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusion of deep venous thrombosis with D-dimer testing: a rebuttal--modified simpliRED methodology is not validated for clinical use.
    Gerometta M; Rowbury D; Cooper B
    Thromb Haemost; 2000 Dec; 84(6):1134-5. PubMed ID: 11154136
    [No Abstract]   [Full Text] [Related]  

  • 20. Is it acceptable to use coagulation plasma samples stored at room temperature and 4°C for 24 hours for additional prothrombin time, activated partial thromboplastin time, fibrinogen, antithrombin, and D-dimer testing?
    Rimac V; Coen Herak D
    Int J Lab Hematol; 2017 Oct; 39(5):475-481. PubMed ID: 28488785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.